Sigma Additive Solutions Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Details Narrative)

Stockholders’ Equity (Details Narrative)					1 Months Ended							3 Months Ended		6 Months Ended		12 Months Ended
Stockholders’ Equity (Details Narrative)	Mar. 31, 2022 $ / shares shares	Feb. 16, 2022 $ / shares shares	Jan. 03, 2022 $ / shares shares	Mar. 26, 2021 shares	Jun. 30, 2022 USD ($) $ / shares shares	Mar. 31, 2022 $ / shares shares	Feb. 28, 2022 $ / shares shares	Mar. 31, 2021 USD ($) $ / shares shares	Feb. 28, 2021 shares	Jan. 31, 2021 USD ($) $ / shares shares	Jan. 31, 2020 $ / shares shares	Jun. 30, 2022 USD ($) $ / shares shares	Jun. 30, 2021 USD ($)	Jun. 30, 2022 USD ($) $ / shares shares	Jun. 30, 2021 USD ($) shares	Dec. 31, 2021 $ / shares shares	May 24, 2021 shares	Mar. 25, 2021 shares
Subsidiary, Sale of Stock [Line Items]
Common stock, shares authorized				24,000,000	24,000,000			12,000,000				24,000,000		24,000,000		24,000,000		12,000,000
Common stock issued during period										1,711,783
Share price per share \| $ / shares										$ 3.00
Proceeds from public offering \| $										$ 4,532,445
Warrants to purchase shares of common stock				2,190,000						136,943
Warrant exercise price \| $ / shares										$ 3.75
Number of shares, warrants exercised																495,641
Warrants exercisable date				May 24, 2021
Preferred stock, shares authorized					10,000,000							10,000,000		10,000,000		10,000,000
Preferred stock, par value \| $ / shares					$ 0.001							$ 0.001		$ 0.001		$ 0.001
Preferred stock, shares issued					465							465		465		465
Preferred stock, shares outstanding					465							465		465		465
Number of shares granted														162,000		698,831
Allocation share based compensation expense \| $												$ 167,439	$ 116,441	$ 338,415	$ 233,919
Options exercise price \| $ / shares														$ 1.28
Stock options compensation cost \| $					$ 990,838							$ 990,838		$ 990,838
Weighted average remaining recognition period														1 year 9 months 7 days
Directors [Member]
Subsidiary, Sale of Stock [Line Items]
Number of shares granted						56,000
Option strike price \| $ / shares	$ 2.50				$ 2.50	$ 2.50						$ 2.50		$ 2.50
Stock option grant percentage														50.00%
Stock option remaining grant percentage														50.00%
Four Employees [Member]
Subsidiary, Sale of Stock [Line Items]
Number of shares granted														22,000
President and CEO [Member]
Subsidiary, Sale of Stock [Line Items]
Number of shares granted							70,000
Option strike price \| $ / shares							$ 2.50
Options exercise price \| $ / shares		$ 2.50
Common shares granted for the period		30,000
Two Consultants [Member]
Subsidiary, Sale of Stock [Line Items]
Number of shares granted						14,000
Option strike price \| $ / shares	2.50					$ 2.50
Eleven Employees [Member]
Subsidiary, Sale of Stock [Line Items]
Options exercise price \| $ / shares			$ 1.87
Common shares granted for the period			12,033
Consultant [Member]
Subsidiary, Sale of Stock [Line Items]
Options exercise price \| $ / shares	$ 2.50
Common shares granted for the period	3,000
2013 Stock Option Plan [Member]
Subsidiary, Sale of Stock [Line Items]
Common stock shares reserved for issuance					201,861							201,861		201,861
2020 Stock Appreciation Rights Plan [Member]
Subsidiary, Sale of Stock [Line Items]
Options exercise price \| $ / shares														$ 1.28
Weighted average remaining recognition period														2 years
Number of shares granted														0
Unrecognized share based compensation cost \| $					$ 577,981							$ 577,981		$ 577,981
Investor [Member]
Subsidiary, Sale of Stock [Line Items]
Share price per share \| $ / shares								$ 4.99
Stock issued during the period, service rendered								1,500
April 2020 Offering [Member]
Subsidiary, Sale of Stock [Line Items]
Common stock issued during period								21,591
Number of shares, warrants exercised								191,204
Placement Agent Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Warrant exercise price \| $ / shares								$ 5.55625
Placement Agent Warrants [Member] \| Measurement Input, Share Price [Member]
Subsidiary, Sale of Stock [Line Items]
Percentage of warrant exercise price								1.25
Common Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Common stock issued during period															3,901,783
Stock issued during the period, service rendered															1,500
Common Stock [Member] \| Placement Agent Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants to purchase shares of common stock								175,200
Percentage of warrant exercise price								0.08
Common Stock [Member] \| Placement Agent Warrants [Member] \| Measurement Input, Share Price [Member]
Subsidiary, Sale of Stock [Line Items]
Percentage of warrant exercise price								8
Series D Convertible Preferred Stock [Member] \| Common Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Conversion of stock shares converted								250
Number of shares as in-kind payment, shares								19,000
Series D Preferred Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Common stock issued during period					87,267
Preferred stock, shares outstanding					132							132		132
Series D Preferred Stock [Member] \| Institutional Securities Purchase Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Preferred stock, par value \| $ / shares											$ 1,000
Sale of shares											1,640
Dividend percentage											9.00%
Conversion price per share \| $ / shares											$ 2.50
Conversion description											Alternatively, a holder may at any time convert all, or any part, of its Series D Preferred Shares at an alternative conversion price equal to the lower of the applicable conversion price then in effect, and the greater of (x) $1.80 and (y) 85% of the average volume weighted average price (“VWAP”) of the Common Stock for a five trading day period prior to such conversion. Upon the occurrence of certain triggering events, described in the Certificate of Designations, including, but not limited to payment defaults, breaches of transaction documents, failure to maintain listing on the Nasdaq Capital Market, and other defaults set forth therein, the Series D Preferred Shares would become subject to redemption, at the option of a holder, at a 125% premium to the underlying value of the Series D Preferred Stock being redeemed.
Series E Preferred Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Common stock issued during period					61,651
Preferred stock, shares outstanding					333							333		333
Series E Preferred Stock [Member] \| Other Securities Purchase Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Conversion of stock shares converted					48,544
Preferred stock, par value \| $ / shares					$ 1,000							$ 1,000		$ 1,000
Sale of shares					333
Dividend percentage					9.00%
Private Placement [Member]
Subsidiary, Sale of Stock [Line Items]
Common stock issued during period								119,000	263,200
Private Placement [Member] \| Purchase Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants to purchase shares of common stock								2,190,000
Warrant exercise price \| $ / shares								$ 4.32
Public Offering [Member]
Subsidiary, Sale of Stock [Line Items]
Common stock issued during period								2,190,000
Share price per share \| $ / shares								$ 4.445
Proceeds from public offering \| $								$ 8,736,487
Minimum [Member]
Subsidiary, Sale of Stock [Line Items]
Common stock, shares authorized																	12,000,000
Maximum [Member]
Subsidiary, Sale of Stock [Line Items]
Common stock, shares authorized																	24,000,000